SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-24-003889
Filing Date
2024-03-26
Accepted
2024-03-26 08:30:20
Documents
18
Period of Report
2024-03-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K kala-20240325x8k.htm   iXBRL 8-K 50435
2 EX-3.1 kala-20240325xex3d1.htm EX-3.1 56209
3 EX-4.1 kala-20240325xex4d1.htm EX-4.1 4052
4 EX-10.1 kala-20240325xex10d1.htm EX-10.1 220542
5 GRAPHIC kala-20240325xex4d1g001.jpg GRAPHIC 204351
6 GRAPHIC kala-20240325xex4d1g002.jpg GRAPHIC 103802
  Complete submission text file 0001558370-24-003889.txt   940461

Data Files

Seq Description Document Type Size
7 EX-101.SCH kala-20240325.xsd EX-101.SCH 3128
8 EX-101.LAB kala-20240325_lab.xml EX-101.LAB 15921
9 EX-101.PRE kala-20240325_pre.xml EX-101.PRE 10121
21 EXTRACTED XBRL INSTANCE DOCUMENT kala-20240325x8k_htm.xml XML 4862
Mailing Address 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476
Business Address 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476 781-996-5252
KALA BIO, Inc. (Filer) CIK: 0001479419 (see all company filings)

IRS No.: 270604595 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38150 | Film No.: 24781025
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)